These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 27876500)

  • 1. Strong correlation between ASPM gene expression and HCV cirrhosis progression identified by co-expression analysis.
    Wang F; Chang Y; Li J; Wang H; Zhou R; Qi J; Liu J; Zhao Q
    Dig Liver Dis; 2017 Jan; 49(1):70-76. PubMed ID: 27876500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Co-expression network analysis identified six hub genes in association with metastasis risk and prognosis in hepatocellular carcinoma.
    Chen P; Wang F; Feng J; Zhou R; Chang Y; Liu J; Zhao Q
    Oncotarget; 2017 Jul; 8(30):48948-48958. PubMed ID: 28430663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Gene Network Associated with HCV-Related Hepatocellular Carcinoma Using Microarray Analysis.
    Cheng Y; Ping J; Chen J
    Pathol Oncol Res; 2018 Jul; 24(3):507-514. PubMed ID: 28669080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion of information throughout the host interactome reveals gene expression variations in network proximity to target proteins of hepatitis C virus.
    Mosca E; Alfieri R; Milanesi L
    PLoS One; 2014; 9(12):e113660. PubMed ID: 25461596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative analysis of hepatocellular carcinoma and cirrhosis gene expression profiles.
    Jiang M; Zeng Q; Dai S; Liang H; Dai F; Xie X; Lu K; Gao C
    Mol Med Rep; 2017 Jan; 15(1):380-386. PubMed ID: 27959423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A personalized approach identifies disturbed pathways and key genes in hepatitis C virus-cirrhosis with hepatocellular carcinoma.
    Li YL; Zheng MX; Wang G
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4266-4273. PubMed ID: 27831648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma in HCV-infected patients awaiting liver transplantation: genes involved in tumor progression.
    Mas VR; Maluf DG; Stravitz R; Dumur CI; Clark B; Rodgers C; Ferreira-Gonzalez A; Fisher RA
    Liver Transpl; 2004 May; 10(5):607-20. PubMed ID: 15108252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin (BIRC5) cell cycle computational network in human no-tumor hepatitis/cirrhosis and hepatocellular carcinoma transformation.
    Wang L; Huang J; Jiang M; Sun L
    J Cell Biochem; 2011 May; 112(5):1286-94. PubMed ID: 21312234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specific gene-expression profiles of noncancerous liver tissue predict the risk for multicentric occurrence of hepatocellular carcinoma in hepatitis C virus-positive patients.
    Okamoto M; Utsunomiya T; Wakiyama S; Hashimoto M; Fukuzawa K; Ezaki T; Hanai T; Inoue H; Mori M
    Ann Surg Oncol; 2006 Jul; 13(7):947-54. PubMed ID: 16788756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene expression profiling of hepatocellular carcinoma by a network analysis approach shows a dominance of intrinsically disordered proteins (IDPs) between hub nodes.
    Singh S; Colonna G; Di Bernardo G; Bergantino F; Cammarota M; Castello G; Costantini S
    Mol Biosyst; 2015 Nov; 11(11):2933-45. PubMed ID: 26267014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genes involved in viral carcinogenesis and tumor initiation in hepatitis C virus-induced hepatocellular carcinoma.
    Mas VR; Maluf DG; Archer KJ; Yanek K; Kong X; Kulik L; Freise CE; Olthoff KM; Ghobrial RM; McIver P; Fisher R
    Mol Med; 2009; 15(3-4):85-94. PubMed ID: 19098997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. From cirrhosis to hepatocellular carcinoma in HCV-infected patients: genes involved in tumor progression.
    Wang Y; Li J; Chen J; Liu L; Peng Z; Ding J; Ding K
    Eur Rev Med Pharmacol Sci; 2012 Aug; 16(8):995-1000. PubMed ID: 22913147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significance of Identifying Key Genes Involved in HBV-Related Hepatocellular Carcinoma for Primary Care Surveillance of Patients with Cirrhosis.
    Li Y; Li J; He T; Song Y; Wu J; Wang B
    Genes (Basel); 2022 Dec; 13(12):. PubMed ID: 36553600
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Integrative network analysis identifies key genes and pathways in the progression of hepatitis C virus induced hepatocellular carcinoma.
    Zheng S; Tansey WP; Hiebert SW; Zhao Z
    BMC Med Genomics; 2011 Aug; 4():62. PubMed ID: 21824427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of proproliferative genes and the ligand/receptor pair placental growth factor and vascular endothelial growth factor receptor 1 in hepatitis C cirrhosis.
    Huang XX; McCaughan GW; Shackel NA; Gorrell MD
    Liver Int; 2007 Sep; 27(7):960-8. PubMed ID: 17696935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signature molecules expressed differentially in a liver disease stage-specific manner by HIV-1 and HCV co-infection.
    Whitmill A; Kim S; Rojas V; Gulraiz F; Afreen K; Jain M; Singh M; Park IW
    PLoS One; 2018; 13(8):e0202524. PubMed ID: 30138348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic gene expression profiles associated with fibrosis progression and hepatocarcinogenesis in hepatitis C patients.
    Shao RX; Hoshida Y; Otsuka M; Kato N; Tateishi R; Teratani T; Shiina S; Taniguchi H; Moriyama M; Kawabe T; Omata M
    World J Gastroenterol; 2005 Apr; 11(13):1995-9. PubMed ID: 15800993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disease progression from chronic hepatitis C to cirrhosis and hepatocellular carcinoma is associated with repression of interferon regulatory factor-1.
    Zekri AR; Moharram RA; Mohamed WS; Bahnassy AA; Alam El-Din HM; Abo-Shadi MM; Zayed NA; El-Magzangy H; Abdel-Aziz AO; Esmat G
    Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):450-6. PubMed ID: 19858727
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
    Llovet JM; Chen Y; Wurmbach E; Roayaie S; Fiel MI; Schwartz M; Thung SN; Khitrov G; Zhang W; Villanueva A; Battiston C; Mazzaferro V; Bruix J; Waxman S; Friedman SL
    Gastroenterology; 2006 Dec; 131(6):1758-67. PubMed ID: 17087938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ASPM is a novel marker for vascular invasion, early recurrence, and poor prognosis of hepatocellular carcinoma.
    Lin SY; Pan HW; Liu SH; Jeng YM; Hu FC; Peng SY; Lai PL; Hsu HC
    Clin Cancer Res; 2008 Aug; 14(15):4814-20. PubMed ID: 18676753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.